Lyka Labs Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lyka Labs Ltd. on BSE

Load latest

Lyka Labs Ltd.

15 May 2024

97.23

1.21%

Corp. Note

LYKA LABS LTD. - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation of issue of duplicate share certificates with the details mentioned therein.

pdf

Lyka Labs Ltd.

14 May 2024

97.23

1.21%

Company Update

LYKA LABS LTD. - 500259 - Update on board meeting

BSE India

The Board Meeting to be held on 21/05/2024 has been revised to 21/05/2024 Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation to our prior intimations dated 10th May 2024, relating to the Board Meeting scheduled on Tuesday, 21st May 2024, this is to inform you that the said meeting is rescheduled at 03:30 p.m. instead of 12:00 noon, inter alia to consider and approve Audited Standalone and Consolidated Financial Results for the quarter and financial year ended on 31st March 2024.

pdf

Lyka Labs Ltd.

10 May 2024

97.23

1.21%

Board Meeting

LYKA LABS LTD. - 500259 - Board Meeting Intimation for Intimation Of Board Meeting To Be …

BSE India

LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 ,inter alia, to consider and approve The Company has informed that the meeting of Board of Directors of the Company is scheduled on 21st May 2024 to consider and approve standalone and consolidated financial results for the year ended 31st March 2024.

pdf

Lyka Labs Ltd.

26 Apr 2024

97.23

1.21%

Corp. Note

LYKA LABS LTD. - 500259 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyLYKA LABS LTD. 2CIN NO.L24230GJ1976PLC008738 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 44.23 4Highest Credit Rating during the previous FY BBB+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Kishore P Shah Designation: Company Secretary and Compliance Officer EmailId: companysecretary@lykalabs.com Name of the Chief Financial Officer: Yogesh Shah Designation: Executive Director and CFO EmailId: ybshah@lykalabs.com Date: 26/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Lyka Labs Ltd.

18 Apr 2024

97.23

1.21%

Company Update

LYKA LABS LTD. - 500259 - Update On The Scheme Of Amalgamation

BSE India

Update on the Scheme of Amalgamation w.r.t its next hearing is enclosed herewith.

pdf

Lyka Labs Ltd.

18 Apr 2024

97.23

1.21%

Company Update

LYKA LABS LTD. - 500259 - Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure …

BSE India

Certificate under Regulation 7 (3) of the SEBI ( Listing Regulations and Disclosure Requirements) Regulation, 2015 is enclosed.

pdf

Lyka Labs Ltd.

18 Apr 2024

97.23

1.21%

SAST

LYKA LABS LTD. - 500259 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ipca Laboratories Ltd & PACs

pdf

Lyka Labs Ltd.

16 Apr 2024

97.23

1.21%

Company Update

LYKA LABS LTD. - 500259 - Certificate Under Regulation 40(9) Of The SEBI (Listing Obligation And …

BSE India

Certificate under regulation 40 (9) of the SEBI LODR Regulations 2015 is submitted herewith.

pdf

Lyka Labs Ltd.

16 Apr 2024

97.23

1.21%

Board Meeting

LYKA LABS LTD. - 500259 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

Outcome of Board Meeting

pdf

Lyka Labs Ltd.

08 Apr 2024

97.23

1.21%

Board Meeting

LYKA LABS LTD. - 500259 - Board Meeting Intimation for Intimation Of Board Meeting To Be …

BSE India

LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/04/2024 ,inter alia, to consider and approve to allot and issue 2600000 equity shares upon conversion of 2600000 warrants to Ipca Laboratories Limited.

pdf

Is Lyka Labs Ltd. worth buying?

47 Votes:

Buy 82.98%

Sell 6.38%

Hold 10.64%